Aficamten
- Generic Name
- Aficamten
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H19N5O2
- CAS Number
- 2364554-48-1
- Unique Ingredient Identifier
- B1I77MH6K1
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Effect of Aficamten in Pediatric Patients (Age 12 to <18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
- Conditions
- Interventions
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Cytokinetics
- Target Recruit Count
- 40
- Registration Number
- NCT06412666
- Locations
- ๐บ๐ธ
Morristown Medical Center, Morristown, New Jersey, United States
๐บ๐ธChildren's Mercy Hospital, Kansas City, Missouri, United States
๐บ๐ธOregon Health & Science University, Portland, Oregon, United States
An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT06116968
- Locations
- ๐จ๐ณ
Fuwai Hospital, CAMS & PUMC, Beijing, China
๐จ๐ณThe Second Affiliated Hospital of Nanchang University, Jiangxi, China
๐จ๐ณThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
- Conditions
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Cytokinetics
- Target Recruit Count
- 420
- Registration Number
- NCT06081894
- Locations
- ๐บ๐ธ
Virginia Mason Medical Center, Seattle, Washington, United States
๐บ๐ธMedical College of Wisconsin/Froedtert Hospital, Milwaukee, Wisconsin, United States
๐ง๐ทFundacao Felice Rocho / Hospital Felicio Rocho, Minas Gerais, Brazil
Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval
- Conditions
- Interventions
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Cytokinetics
- Target Recruit Count
- 44
- Registration Number
- NCT05924815
- Locations
- ๐บ๐ธ
Celerion, Inc 2420, Tempe, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.